Sort
15,842 grants matching “pancreatic cancer”
Reprogramming PDAC tumor microenvironment to improve immunotherapy
$577,095Rakesh K. Jain · Massachusetts General Hospital · U01 · FY2021 · CA
Reprogramming PDAC tumor microenvironment to improve immunotherapy
$577,095Rakesh K. Jain · Massachusetts General Hospital · U01 · FY2020 · CA
Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in Cancer
$577,035Eric Collisson · University Of California, San Francisco · R01 · FY2021 · CA
Processed Antigen Characterization by Mass Spectrometry
$577,016Donald F Hunt · University Of Virginia · R01 · FY2010 · AI
Signal Transduction by Tyrosine Phosphorylation
$577,006Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2015 · CA
Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma
$576,934Christopher A Klug · University Of Alabama At Birmingham · P50 · FY2011 · CA
Mechanisms of Murine Turmor Eradication by Immunotherapy
$576,505Philip D Greenberg · University Of Washington · R01 · FY2016 · CA
Molecular Epidemiology of Pancreatic Cancer
$576,384Elizabeth A. Holly · University Of California, San Francisco · R01 · FY2006 · CA
Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma
$576,372Christopher A Klug · University Of Alabama At Birmingham · P50 · FY2014 · CA
The Investigation of disease causing genes in C. elegans
$576,181Andy Golden · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
The MYC Transcription Factor Network and the Path to Cancer
$576,145Robert Neil Eisenman · Fred Hutchinson Cancer Research Center · R35 · FY2021 · CA
Genomic and genetic studies of endocrine cancers
$576,047Electron Kebebew · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Project 1
$576,031David J Odde · University Of Minnesota · P01 · FY2021 · CA
Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer
$575,997Kenneth H. Yu · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer
$575,993Kenneth H. Yu · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer
$575,967Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2021 · CA
DIRECTLY CONJUGATED SINGLE-DOMAIN VHHS TARGETING MHC CLASS II PRIME T-CELL RESPONSES AGAINST PANCREATIC CANCER NEOANTIGENS
$575,938Dana-Farber Cancer Institute, Inc. · · FY2016 · Department of Defense
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer
$575,892Timothy R Donahue · University Of California Los Angeles · R01 · FY2024 · CA
The Antigen Targeting Core
$575,890Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
$575,716Farrokh Dehdashti · Washington University · R01 · FY2019 · CA
Designing a Plan of Action for Better Access and Quality of Surgery for African-Americans with Gastrointestinal Cancers in the Deep South
$575,534Maria Pisu · University Of Alabama At Birmingham · R01 · FY2024 · MD
The Prognostic Significance and Mechanistic Determination of Chromatin Remodeling Biomarkers in Non-Functional Pancreatic Neuroendocrine Tumor
$575,488Aatur Dilip Singhi · University Of Pittsburgh At Pittsburgh · R37 · FY2023 · CA
Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples
$575,420Tony Y. Hu · Tulane University Of Louisiana · U01 · FY2024 · CA
The adaptive kinome in pancreatic cancer
$575,301Jen Jen Yeh · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Leveraging CD26high Meso-CAR T cells in patients with advanced pancreatic cancer
$575,241Gregory B. Lesinski · Emory University · R01 · FY2024 · CA